Serenoa repens (W.B. Bartram) Small — also called Sabal serrulata — a small fan palm native to the southeastern United States, whose berry extract is the most widely used and most extensively studied herbal supplement for benign prostatic hyperplasia, with an evidence base that has shifted substantially as larger, more rigorous trials have accumulated.
Saw palmetto is a small fan palm, spontaneous in the sandy soils of the southeastern United States, where it covers roughly 10% of Florida's land area. It has a short, single trunk (0.5–2 m), blue-green fan-shaped leaves, and a spiny petiole. Its globular, bluish-black berry was eaten as food in pre-Columbian times.
Saw palmetto berries were eaten as food by pre-Columbian peoples of Florida. Today, Florida exports roughly 6,800 tonnes of berries to Europe each year to supply the pharmaceutical industry, making it one of the most commercially significant medicinal palms in the world.
Few herbs illustrate the evolution of clinical evidence as clearly as this one. Smaller European trials through the 1980s and 1990s, and a 2002 Cochrane review, reported meaningful symptom improvement for benign prostatic hyperplasia (BPH). But as larger, longer, NIH-funded trials were conducted in the 2000s, the picture changed substantially — see the timeline.
⚠ Read This Before the Properties Section
Saw palmetto has a well-documented mechanism of action in laboratory studies. But mechanism is not the same as proven clinical benefit — the largest human trials to date found no improvement over placebo. Both threads are presented honestly throughout this monograph.
Saw palmetto's research has always centered on the whole lipidosterolic extract rather than one isolated active ingredient.
The hexanic or supercritical-CO2 extract is dominated by free fatty acids — predominantly lauric, oleic, and myristic acid — standardized to 70–95% free fatty acid content.
Beta-sitosterol, campesterol, stigmasterol, and cycloartenol are present, alongside anthranilic acid, farnesol, and carotenoids.
Decreased binding between dihydrotestosterone and its cytosolic receptors has been demonstrated with hexanic extracts, but not with alcoholic extracts — the extraction method genuinely matters.
The hydroalcoholic extract additionally contains flavonoids, including rutin and isoquercitin.
⚠ The 2023 Cochrane Review Found No Difference by Extraction Method
Hexane vs. non-hexane extracts performed equally — neither showed benefit over placebo.
Earlier mechanistic work suggested hexanic extracts were more biologically active than alcoholic ones in the lab. The 2023 Cochrane review found this distinction did not translate into a meaningful clinical difference — both extract types showed similarly limited benefit over placebo in the largest pooled analysis to date.
Only the berry is used medicinally, in two principal commercial forms.
The standard commercial form, obtained using n-hexane, 95% alcohol, or supercritical CO2, then standardized to 70–95% free fatty acids and concentrated to a 10:1 ratio. This is the form used in nearly all major clinical trials.
Standardized Extract
A traditional alcoholic tincture of the berry, less concentrated and less commonly studied than the lipidosterolic extract.
Traditional · Liquid
The single dose given in the primary source.
A lipid-dominant profile, with composition varying by extraction method.
Documented peripheral anti-androgenic activity in laboratory studies.
Documented reduction of post-void residual volume in the primary mechanistic literature.
Inhibits testosterone-5-alpha-reductase, interfering with prostatic testosterone metabolism, and also inhibits 3-alpha-ketosteroid reductase.[1][3]
Reduces growth of human prostate cancer cell lines without interfering with cells' capacity to secrete PSA, preserving PSA as a usable screening measure.[1][2]
Decreases binding between dihydrotestosterone (DHT) and its cytosolic receptors — demonstrated with hexanic extracts, but not with alcoholic extracts.
Hexanic extracts inhibit binding of methyltrienolone to DHT cytosolic receptors.
Inhibits cyclooxygenase and lipoxygenase, producing an anti-inflammatory and anti-edematous effect.
Traditional indications, framed against what current guideline bodies actually recommend.
Three proposed mechanisms for BPH, per the primary phytotherapy literature.
Limits the conversion of testosterone to dihydrotestosterone (DHT) at the prostatic level, theoretically reducing hypertrophy-related symptoms.[10]
Inhibits DHT binding to androgen receptors, theoretically preventing further prostate growth.[10]
Anti-inflammatory action via inhibition of eicosanoid synthesis.[10]
All three mechanisms are supported by laboratory and cell-culture data, reviewed comprehensively in the literature. None has yet translated into a clinical benefit detectable in the largest, longest randomized trials conducted to date.[11][12][13][22]
One of the better safety profiles among herbal supplements — even the trials that found no benefit confirmed it was well tolerated.